Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high‐risk donor seropositive/recipient seronegative heart transplant recipients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high‐risk donor seropositive/recipient seronegative heart transplant recipients
Authors
Keywords
-
Journal
Transplant Infectious Disease
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-05
DOI
10.1111/tid.13255
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytomegalovirus infection in heart transplantation: A single center experience
- (2018) Ignacio A. Echenique et al. Transplant Infectious Disease
- Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin
- (2018) Mari Eriksson et al. Transplant Infectious Disease
- Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study
- (2018) Johannes Goekler et al. TRANSPLANT INTERNATIONAL
- The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
- (2018) Camille N. Kotton et al. TRANSPLANTATION
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
- (2016) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
- (2015) Inger Johansson et al. BMC INFECTIOUS DISEASES
- Cytomegalovirus in Solid Organ Transplantation
- (2013) R. R. Razonable et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation
- (2013) Scott M. Palmer ANNALS OF INTERNAL MEDICINE
- High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy
- (2013) Heli Harvala et al. JOURNAL OF MEDICAL VIROLOGY
- Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
- (2012) Andreas Doesch et al. Drug Design Development and Therapy
- Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial
- (2011) C. Ashley Finlen Copeland et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance
- (2010) Martha T. van der Beek et al. TRANSPLANTATION
- Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study
- (2010) Atul Humar et al. TRANSPLANTATION
- Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
- (2010) Noémie Boillat Blanco et al. TRANSPLANTATION
- Prophylactic Therapy With Valgancyclovir in High-Risk (Cytomegalovirus D+/R−) Liver Transplant Recipients: A Single-Center Experience
- (2009) M. Montejo et al. TRANSPLANTATION PROCEEDINGS
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
- (2008) D. J. Winston et al. BLOOD
- High Incidence of Cytomegalovirus Disease in D+/R− Heart Transplant Recipients Shortly After Completion of 3 Months of Valganciclovir Prophylaxis
- (2008) Sachin Gupta et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now